COMPREHENSIVE STUDY OF THE PLANT RAW MATERIAL PULMONARIA MOLLIS WULFEN EX HORNEM (BORAGINACEAE JUSS)

2025

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.26577/bb202510214
Data confidence 85 high
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Studiеs оf mеdicinal flоra fоr thе presence of new biologically important components and identification of potentially significant plant species, occupy a special niche in the development of drugs based on plant raw materials. In official medicine, medicinal plants are increasingly used and prioritized in the treatment and prevention of many diseases [1]. Long-term studies of medicinal plants have shown that extracts from them have low toxicity and exhibit therapeutic properties, and the variety of biologically active substances provides a wide range of pharmacological actions of plant preparations. Based on literature data, Pulmonaria mollis is rich in polyphenolic compounds, glycosides (rosmarinic acid), naphthaquinones, terpenes, heterocyclic compounds – allantoin, and many of them have pronounced antioxidant, antibacterial and anti-inflammatory activity. A comprehensive study was conducted on the aboveground part of Pulmonaria mollis Wulfen ex Hornem., growing in the Alakol District of the Zhetysu Region, Republic of Kazakhstan. The content of biogenic ...